Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial

IMPORTANCE: Impairment of dopaminergic transmission may contribute to cognitive dysfunction in Alzheimer disease (AD). OBJECTIVE: To investigate whether therapy with dopaminergic agonists may affect cognitive functions in patients with AD. DESIGN, SETTING, AND PARTICIPANTS: This phase 2, monocentric...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:JAMA Netw Open
मुख्य लेखकों: Koch, Giacomo, Motta, Caterina, Bonnì, Sonia, Pellicciari, Maria Concetta, Picazio, Silvia, Casula, Elias Paolo, Maiella, Michele, Di Lorenzo, Francesco, Ponzo, Viviana, Ferrari, Clarissa, Scaricamazza, Eugenia, Caltagirone, Carlo, Martorana, Alessandro
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Medical Association 2020
विषय:
Original Investigation
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364345/
https://ncbi.nlm.nih.gov/pubmed/32667654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.10372
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन